| Schedule of reconciliation of the denominators of the basic and diluted income (loss) per share | |
| | |
| | |
| | |
| |
| | |
Three months ended March 31,
2026 | | |
Three months ended March 31, 2025 | | |
Nine months ended March 31, 2026 | | |
Nine months ended March 31, 2025 | |
| Shares issued – beginning of period | |
| 57,996,635 | | |
| 57,236,479 | | |
| 57,386,476 | | |
| 57,227,248 | |
| Shares held by subsidiaries (Note 7) | |
| (704,309 | ) | |
| (704,309 | ) | |
| (704,309 | ) | |
| (704,309 | ) |
| Shares outstanding – beginning of period | |
| 57,292,326 | | |
| 56,532,170 | | |
| 56,682,167 | | |
| 56,522,939 | |
Weighted average shares issued
during the period | |
| 12,274 | | |
| 64,999 | | |
| 261,203 | | |
| 30,076 | |
Diluted weighted average shares –
end of period | |
| 57,304,600 | | |
| 56,597,169 | | |
| 56,943,370 | | |
| 56,553,015 | |